Cognetivity Neurosciences Ltd.
CGNSF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.84K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8,837.00 |
|---|---|
| Enterprise Value | $2.84 Million |
| Earnings per Share | $-0.09 |
| Beta | 0.74 |
| Outstanding Shares | 88,368,631 |
Return
| Return on Equity | 56.88% |
|---|---|
| Return on Assets | -1776.17% |
| Return on Invested Capital | 26.95% |
Valuation & Multiples
| P/E Ratio | -0.13 |
|---|---|
| PEG | -0.93 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 28.66 |
| Enterprise Value to EBIT | -0.69 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -0.19 |
Revenue Sources
No data
Next Earnings Call
Expected Date
January 1, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Cognetivity Neurosciences Ltd.
2,500 employees
CEO: Sina Habibi
Cognetivity Neurosciences Ltd. is a healthcare firm focused on advanced cognitive assessment. The company has developed a sophisticated platform for cognitive testing, designed for use across diverse settings including medical facilities...